Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Australia
  4. Australian Stock Exchange
  5. Incannex Healthcare Limited
  6. Summary
    IHL   AU000000IHL8

INCANNEX HEALTHCARE LIMITED

(IHL)
  Report
Delayed Australian Stock Exchange  -  12:10 2022-11-30 am EST
0.2300 AUD   -2.13%
12/01Incannex Healthcare : ASX Announcement, dated December 01, 2022 – Trading Halt - Form 6-K
PU
11/29Incannex kicks off manufacture of skin therapeutics
AQ
11/29Incannex kicks off manufacture of skin therapeutics
EQ
 SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisionsFunds 
Quotes 5-day view   Delayed Quote. Delayed Australian Stock Exchange
11/24/2022 11/25/2022 11/28/2022 11/29/2022 11/30/2022 Date
0.255(c) 0.245(c) 0.24(c) 0.235(c) 0.23(c) Last
1 817 707 1 793 427 882 545 3 767 540 1 405 045 Volume
+2.00% -3.92% -2.04% -2.08% -2.13% Change
More quotes
Estimated financial data (e)
Sales 2023 - - -
Net income 2023 - - -
Net Debt 2023 - - -
P/E ratio 2023 -
Yield 2023 -
Sales 2024 - - -
Net income 2024 - - -
Net Debt 2024 - - -
P/E ratio 2024 -
Yield 2024 -
Capitalization 352 M 239 M 239 M
Capi. / Sales 2023 -
Capi. / Sales 2024 -
Nbr of Employees 3
Free-Float 83,8%
More Financials
Company
Incannex Healthcare Limited is an Australia-based clinical-stage pharmaceutical development company. The Company is focused on developing medicinal cannabis pharmaceutical products and psychedelic medicine therapies for the treatment of generalized anxiety disorder (GAD), obstructive sleep apnea (OSA), traumatic brain injury (TBI)/concussion, lung inflammation, rheumatoid arthritis and inflammatory bowel disease.... 
Sector
Pharmaceuticals
Calendar
02/28Earnings Release
More about the company
All news about INCANNEX HEALTHCARE LIMITED
12/01Incannex Healthcare : ASX Announcement, dated December 01, 2022 – Trading Halt - For..
PU
11/29Incannex kicks off manufacture of skin therapeutics
AQ
11/29Incannex kicks off manufacture of skin therapeutics
EQ
11/29Incannex Engages Eurofins to Manufacture ReneCann Therapeutic Topical Application for I..
AQ
11/29Date : November 29, 2022 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K
PU
11/28Incannex Healthcare Taps Contract Manufacturer for Topical Drug Production
MT
11/28Incannex Healthcare Limited Engages Eurofins to Manufacture ReneCann Therapeutic Topica..
CI
11/28Incannex Healthcare Taps Eurofins Scientific to Manufacture Medicated Chewable Products
MT
11/28Incannex Engages Eurofins to Manufacture Novel Addiction Treatments CannQuit-N and Cann..
AQ
11/25Date : November 25, 2022 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K
PU
11/24Incannex Healthcare Taps Eurofins Scientific for Manufacturing Medicated Chewables
MT
11/17Incannex Development Update for IHL-42X for Obstructive Sleep Apnoea (‘OSA')
AQ
11/17Date : November 17, 2022 Public Announcement (NASDAQ: IXHL) (ASX: IHL) - Form 6-K
PU
11/16Incannex Healthcare Hires Contract Research Organizations for Apnea Drug Study
MT
11/16Incannex Healthcare Limited Announces Development Update for IHL-42X for Obstructive Sl..
CI
More news
News in other languages on INCANNEX HEALTHCARE LIMITED
11/28Incannex Healthcare fait appel à un fabricant sous contrat pour la production de médica..
11/28Incannex Healthcare Limited engage Eurofins pour la fabrication de l'application topiqu..
11/16Incannex Healthcare engage des organismes de recherche sous contrat pour une étude sur ..
11/16Incannex Healthcare Limited annonce une mise à jour du développement du IHL-42X pour l'..
10/13Incannex achève le dosage des patients dans un essai de phase 1 sur un médicament anti-..
More news
ETFs positioned on INCANNEX HEALTHCARE LIMITEDETFs and Trackers with Trackinsight
ETF WeightVar. 5daysRatingGeography
ETFMG Alternative Harvest ETF - USD2.45%10.82%-World
IShares S&P/ASX Small Ordinaries ETF - AUD0.17%1.33%-Australia
More ETFs positioned on INCANNEX HEALTHCARE LIMITED
Chart INCANNEX HEALTHCARE LIMITED
Duration : Period :
Incannex Healthcare Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INCANNEX HEALTHCARE LIMITED
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Managers and Directors
Joel Latham CEO, Group MD & Executive Director
Madhukar Bhalla Chief Financial Officer & Secretary
Troy Valentine Independent Non-Executive Chairman
Mark Bleackley Chief Scientific Officer
Rosemarie Walsh Vice President-Clinical Operations